Cargando…

Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival Benefit

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) with peritoneal dissemination is a highly lethal disease. Recently, promising activity of intraperitoneal chemotherapy with paclitaxel (i.p.-PTX) has been observed in patients with peritoneal dissemination. We conducted a retrospective comparat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto, Tomohisa, Satoi, Sohei, Yamaki, So, Hashimoto, Daisuke, Ishida, Mitsuaki, Ikeura, Tsukasa, Hirooka, Satoshi, Matsui, Yuki, Boku, Shogen, Nakayama, Shinji, Nakamaru, Koh, Shibata, Nobuhiro, Katsushima, Utae, Sekimoto, Mitsugu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909716/ https://www.ncbi.nlm.nih.gov/pubmed/35267661 http://dx.doi.org/10.3390/cancers14051354

Ejemplares similares

Reevaluation of regional lymph nodes in patients with pancreatic ductal adenocarcinoma in the pancreatic body and tail
por: Matsui, Yuki, et al.
Publicado: (2022)

Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma
por: Yanagimoto, Hiroaki, et al.
Publicado: (2020)

Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma
por: Satoi, Sohei, et al.
Publicado: (2019)

The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma
por: Sakaguchi, Tatsuma, et al.
Publicado: (2020)

A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic Cancer
por: Ikoma, Tatsuki, et al.
Publicado: (2023)

Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)
por: Yamamoto, Tomohisa, et al.
Publicado: (2022)

Clinicopathological characteristics of pancreatic ductal adenocarcinoma with invasive micropapillary carcinoma component with emphasis on the usefulness of PKCζ immunostaining for detection of reverse polarity
por: Ryota, Hironori, et al.
Publicado: (2021)

Hepatic actinomycosis after total pancreatectomy: A case report
por: Sakaguchi, Tatsuma, et al.
Publicado: (2021)

Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab
por: Yoshida, Terufumi, et al.
Publicado: (2021)

Prognosis in Patients With Gallbladder Edema Misdiagnosed as Cholecystitis
por: Matsui, Yoichi, et al.
Publicado: (2019)

A clinical role of staging laparoscopy in patients with radiographically defined locally advanced pancreatic ductal adenocarcinoma
por: Satoi, Sohei, et al.
Publicado: (2016)

The academic impact and value of an international online surgery lecture series
por: Hashimoto, Daisuke, et al.
Publicado: (2023)

Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S‐1/Oxaliplatin/Irinotecan) in Patients with Unresectable Pancreatic Ductal Adenocarcinoma
por: Akahori, Takahiro, et al.
Publicado: (2019)

Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis
por: Yamada, S., et al.
Publicado: (2020)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
por: Satoi, Sohei
Publicado: (2021)

Acute median arcuate ligament syndrome after pancreaticoduodenectomy
por: Karabicak, Ilhan, et al.
Publicado: (2016)

Multicenter randomized phase II trial of prophylactic right‐half dissection of superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic head cancer
por: Yamada, Suguru, et al.
Publicado: (2020)

Reappraisal of previously reported meta-analyses on antibiotic prophylaxis for low-risk laparoscopic cholecystectomy: an overview of systematic reviews
por: Matsui, Yoichi, et al.
Publicado: (2018)

Dual‐center randomized clinical trial exploring the optimal duration of antimicrobial prophylaxis in patients undergoing pancreaticoduodenectomy following biliary drainage
por: Yamamoto, Tomohisa, et al.
Publicado: (2018)

Case report: administration of immune checkpoint inhibitor for SMARCB1 (INI1)-negative rhabdoid carcinoma with microsatellite instability (MSI)-high in the right colon
por: Kobayashi, Toshinori, et al.
Publicado: (2023)

Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study
por: Hashimoto, Daisuke, et al.
Publicado: (2022)

Sjögren’s Syndrome Complicated With Sarcoidosis With a Repetitive, Prolonged, Non-productive Cough
por: Nakamura, Takahito, et al.
Publicado: (2022)

Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2020)

Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2021)

Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2021)

Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2021)

Association between fatty acid synthase and adipophilin expression in triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2022)

Immunohistochemical analyses of the expression profiles of INSM1, ATRX, DAXX and DLL3 in solid papillary carcinomas of the breast
por: Yanai, Hirotsugu, et al.
Publicado: (2022)

Prognostic significance of adipophilin expression in biopsy specimens of patients with triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2022)

Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study
por: Yanai, Hirotsugu, et al.
Publicado: (2021)

Prognostic significance of the expression levels of T-cell immunoglobulin mucin-3 and its ligand galectin-9 for relapse-free survival in triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2022)

Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal Malignancy Study Group
por: Satoi, Sohei, et al.
Publicado: (2022)

Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan
por: Ikoma, Tatsuki, et al.
Publicado: (2021)

Tumor budding may be a promising prognostic indicator in intrahepatic cholangiocarcinoma: A multicenter retrospective study
por: Kosaka, Hisashi, et al.
Publicado: (2022)

Intramural bronchogenic cysts of the esophagus and gastroesophageal junction: A case report
por: Matsuda, Hayato, et al.
Publicado: (2020)

Direct comparison of magnetic resonance imaging and pathological shrinkage patterns of triple-negative breast cancer after neoadjuvant chemotherapy
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2020)

Significance of desmoplastic reactions on tumor deposits in patients with colorectal cancer
por: Kobayashi, Toshinori, et al.
Publicado: (2022)

Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy
por: Zhang, Jingjing, et al.
Publicado: (2023)

Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer
por: de Jong, Loek A. W., et al.
Publicado: (2023)

Two cases of primary solitary fibrous tumor in the pelvis resected using laparoscopic surgery
por: Matsui, Yuki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d4i621h8fqhpfgj11fd304ppa7